Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?
Authors
Keywords
Disease Modification, Disease Prediction, Preclinical Disease, Biomarkers
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-04
DOI
10.1053/j.gastro.2021.07.051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD
- (2021) Catherine Le Berre et al. GASTROENTEROLOGY
- Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients
- (2021) Eelco C. Brand et al. GASTROENTEROLOGY
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
- (2021) Dan Turner et al. GASTROENTEROLOGY
- Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease
- (2021) Joana Torres et al. Journal of Crohns & Colitis
- Defining difficult-to-treat inflammatory bowel disease: why and how
- (2021) Silvio Danese et al. Lancet Gastroenterology & Hepatology
- Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families
- (2020) Elizabeth A. Spencer et al. GASTROENTEROLOGY
- Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease
- (2020) Ryan C. Ungaro et al. GASTROENTEROLOGY
- Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis
- (2020) Joana Torres et al. GASTROENTEROLOGY
- Prevention strategies for type 1 diabetes: a story of promising efforts and unmet expectations
- (2020) Anna Kanta et al. Hormones-International Journal of Endocrinology and Metabolism
- Increased Intestinal Permeability is Associated with Later Development of Crohn’s Disease
- (2020) Williams Turpin et al. GASTROENTEROLOGY
- Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
- (2020) Heather J. Galipeau et al. GASTROENTEROLOGY
- Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice
- (2019) Joana Torres et al. GUT
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
- (2018) Danielle M Gerlag et al. ANNALS OF THE RHEUMATIC DISEASES
- Preventing progression from arthralgia to arthritis: targeting the right patients
- (2017) Hanna W. van Steenbergen et al. Nature Reviews Rheumatology
- Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease
- (2016) Paul Lochhead et al. Clinical Gastroenterology and Hepatology
- Serological markers predict inflammatory bowel disease years before the diagnosis
- (2012) Fiona D M van Schaik et al. GUT
- Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network
- (2009) Jay S. Skyler et al. Annals of the New York Academy of Sciences
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search